Nurix Therapeutics to Host R&D Day on May 26, 2022 Portfolio News / Karina Tin May 9, 2022 Nurix Therapeutics to Host R&D Day on May 26, 2022 Read More »
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update Portfolio News / Karina Tin May 9, 2022 ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update Read More »
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress Portfolio News / Karina Tin May 9, 2022 Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress Read More »
NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results Portfolio News / Karina Tin May 5, 2022 NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results Read More »
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires Portfolio News / Karina Tin May 4, 2022 RAPT Therapeutics Expands Leadership Team with Multiple Key Hires Read More »
Plexium Appoints Stephen Mullennix as Chief Financial Officer Portfolio News / Karina Tin May 3, 2022 Plexium Appoints Stephen Mullennix as Chief Financial Officer Read More »
Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Portfolio News / Karina Tin May 2, 2022 Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Read More »
Plexium and Abbvie Enter into Multi-target Strategic Collaboration to Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions Portfolio News / Karina Tin April 28, 2022 Plexium and Abbvie Enter into Multi-target Strategic Collaboration to Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions Read More »
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Adds New Chief Business Officer Portfolio News / Karina Tin April 25th, 2022 Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Adds New Chief Business Officer Read More »
NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022 Portfolio News / Karina Tin April 20, 2022 NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022 Read More »